Refresh

GlaxoSmithKline Pharmaceuticals Ltd. - Research Center

500660 GLAXO Group (A) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20

Sales

3,407.25 3,216.34 3,217.51 3,193.73 3,224.68

Operating profit

900.65 799.41 755.83 694.95 658.45

Interest

1.80 1.81 1.99 3.53 6.34

Gross profit

1,022.33 899.12 830.06 801.61 729.67

EPS (Rs)

34.51 35.87 99.79 21.11 6.50
Annual  results in details
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20

Other income

123.48 101.52 76.22 110.19 77.56

Stock adjustment

-69.64 67.25 13.83 -27.53 -35.43

Raw material

504.99 394.35 552.47 452.64 474.38

Power and fuel

- - - - -

Employee expenses

624.39 594.99 610.23 614.69 628.55

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

1,446.86 1,360.34 1,285.15 1,458.98 1,498.73

Provisions made

- - - - -

Depreciation

69.68 65.77 68.19 79.28 82.68

Taxation

224.35 227.68 396.87 192.17 212.45

Net profit / loss

584.69 607.75 1,690.53 357.56 110.05

Extra ordinary item

-143.61 2.08 1,325.53 -172.60 -324.49

Prior year adjustments

- - - - -

Equity capital

169.41 169.41 169.41 169.41 169.41

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

26.43 24.85 23.49 21.76 20.42

GPM (%)

28.96 27.10 25.20 24.26 22.10

NPM (%)

16.56 18.32 51.33 10.82 3.33
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com